A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant HIV.

Understand the significance of proteo-transcriptomics in identifying vulnerabilities in Candida auris and addressing drug resistance.

For patients with advanced melanoma without BRAF mutation who no longer respond to immune checkpoint inhibitors, treatment ...

Resistant cells demonstrated global decreases in DNA accessibility with localized opening at resistance-driving loci, ...

Antibiotic resistance is one of the world's leading causes of death, claiming the lives of more people than HIV / AIDS or ...

People who have lived with HIV long-term can need up to a dozen pills every day to suppress the virus. Results from a new ...

Long-acting antiviral medications are transforming HIV prevention and care, requiring only minimalistic dosing. But as the use of lenacapavir expands, scientists are probing a critical question: If ...

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

New ‘nanoagents’ can carry drugs straight to infected areas with minimal amounts of drug - reducing the risks of antibiotic resistance.

Accurately modeling irregularly-shaped particles isn’t easy, but a new study found a way to improve a century-old idea.

A University of Alberta research team has identified a new drug target to treat harmful E. coli bacteria—which cause nearly ...

After decades of losing ground to drug resistance, doctors finally have new weapons against gonorrhoea, a common sexually transmitted infec.